ATAI Life Sciences
ATAI
ATAI
88 hedge funds and large institutions have $23.3M invested in ATAI Life Sciences in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less funds holding
Funds holding: 96 → 88 (-8)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
Holders
88
Holding in Top 10
1
Calls
$334K
Puts
$36K
Top Buyers
| 1 | +$5.29M | |
| 2 | +$1.09M | |
| 3 | +$941K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$601K |
| 5 |
JPMorgan Chase & Co
New York
|
+$251K |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$1.41M | |
| 3 | -$1.1M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$359K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$346K |